Targeted Protein Degradation Companies in the UK

Targeted protein degradation companies develop medicines that direct disease-associated proteins towards the cell’s natural disposal machinery. These technologies can remove proteins rather than simply blocking their activity, creating new approaches to previously difficult drug targets.

This category includes companies working on:

PROTACs and heterobifunctional degraders
Molecular glues and induced protein interactions
E3 ligase discovery and recruitment
Degrader screening and optimisation platforms
Targeted protein degradation therapeutics

Browse 13 UK targeted protein degradation companies below.

View full directory

Targeted Protein Degradation

Showing 13–13 of 13

Sort by

UCB Pharma

South East England

Global biopharma focused on severe neurological and immunological diseases

UCB Pharma is the UK subsidiary of UCB S.A., a Belgian biopharmaceutical company focused on the discovery and development of treatments for severe neurological and immunological…

Biopharma

View profile